CASGEVY Makes History as FDA Approves First CRISPR/Cas9 Genome Edited Therapy

被引：23
|
作者：
Philippidis, Alex [1 ]
机构：
[1] Mary Ann Liebert Inc, New Rochelle, NY 10801 USA
来源：
HUMAN GENE THERAPY | 2024年 / 35卷 / 1-2期
关键词：
D O I：
10.1089/hum.2023.29263.bfs
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [1] Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
    Singh, Ajeet
    Irfan, Hamza
    Fatima, Eeshal
    Nazir, Zainab
    Verma, Amogh
    Akilimali, Aymar
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4555 - 4559
  • [2] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193
  • [3] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [4] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [5] The CRISPR/Cas9 Genome Editing Revolution
    Renjie Jiao
    Caixia Gao
    JournalofGeneticsandGenomics, 2016, 43 (05) : 227 - 228
  • [6] CRISPR/Cas9 genome editing in wheat
    Dongjin Kim
    Burcu Alptekin
    Hikmet Budak
    Functional & Integrative Genomics, 2018, 18 : 31 - 41
  • [7] CRISPR/Cas9 and Genome Editing in Drosophila
    Bassett, Andrew R.
    Liu, Ji-Long
    JOURNAL OF GENETICS AND GENOMICS, 2014, 41 (01) : 7 - 19
  • [8] Cascading CRISPR–Cas9 genome edits
    Clyde D.
    Nature Reviews Genetics, 2021, 22 (3) : 134 - 134
  • [9] CRISPR/Cas9 and Genome Editing in Drosophila
    Andrew R.Bassett
    Ji-Long Liu
    JournalofGeneticsandGenomics, 2014, 41 (01) : 7 - 19
  • [10] The CRISPR/Cas9 Genome Editing Revolution
    Jiao, Renjie
    Gao, Caixia
    JOURNAL OF GENETICS AND GENOMICS, 2016, 43 (05) : 227 - 228
12345